BioSymetrics CSO and head of Life Sciences, Gabe is expanding BioSymetrics’ scientific leadership in biopharma R&D informatics, precision medicine, drug compound HTL generation, genomics, imaging and clinical diagnosis. Previously, Gabe was an Associate Scientist at Brigham and Women’s Hospital where his work focused on using machine learning frameworks to predict gene and small molecule function, and identification of disease-causal genes using large-scale genomic datasets. Gabe received his Ph.D. in Molecular Genetics from the University of Toronto. He also received his Masters of Science and undergraduate degrees from the University of Toronto.
“The infrastructure developed by this initiative will propel collaborative Canadian drug discovery efforts for COVID-19,”12 December 2020